Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single-cell resolution

Genome Res. 2023 Jun;33(6):839-856. doi: 10.1101/gr.276765.122. Epub 2023 Jul 13.

Abstract

Synthetic glucocorticoids, such as dexamethasone, have been used as a treatment for many immune conditions, such as asthma and, more recently, severe COVID-19. Single-cell data can capture more fine-grained details on transcriptional variability and dynamics to gain a better understanding of the molecular underpinnings of inter-individual variation in drug response. Here, we used single-cell RNA-seq to study the dynamics of the transcriptional response to glucocorticoids in activated peripheral blood mononuclear cells from 96 African American children. We used novel statistical approaches to calculate a mean-independent measure of gene expression variability and a measure of transcriptional response pseudotime. Using these approaches, we showed that glucocorticoids reverse the effects of immune stimulation on both gene expression mean and variability. Our novel measure of gene expression response dynamics, based on the diagonal linear discriminant analysis, separated individual cells by response status on the basis of their transcriptional profiles and allowed us to identify different dynamic patterns of gene expression along the response pseudotime. We identified genetic variants regulating gene expression mean and variability, including treatment-specific effects, and showed widespread genetic regulation of the transcriptional dynamics of the gene expression response.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19* / genetics
  • Child
  • Gene Expression Regulation
  • Glucocorticoids* / metabolism
  • Glucocorticoids* / pharmacology
  • Humans
  • Leukocytes, Mononuclear / metabolism

Substances

  • Glucocorticoids